ims conference 2022 myeloma

Daratumumab, carfilzomib, lenalidomide and dexamethasone (Dara-KRd), autologous transplantation and MRD response-adapted consolidation and treatment cessation. When 9/6/2023 6:00 AM - 9/9/2023 1:00 PM Central Daylight Time Where He is also an active member of several Bar Associations and several local community organizations. //

ims conference 2022 myeloma